Tenofit 300 Tablet contains Tenofovir Disoproxil Fumarate 300mg, a nucleotide reverse transcriptase inhibitor (NRTI) widely used in antiviral therapy. It is an essential component in the management of HIV-1 infection and chronic hepatitis B virus (HBV) infection, helping control viral replication effectively.
Tenofovir works by inhibiting viral DNA synthesis, preventing the virus from multiplying inside host cells. By reducing viral load, it helps protect the immune system, slow disease progression, and decrease the risk of transmission when used as part of a prescribed treatment regimen.
Clinically, Tenofit 300 Tablet is indicated for HIV-1 infection in combination with other antiretroviral agents and for chronic hepatitis B in adults and adolescents. The tablet formulation ensures consistent dosing, good bioavailability, and ease of long-term administration, supporting better treatment adherence.
Regular use under strict medical supervision helps in maintaining viral suppression, improving liver health in hepatitis B, and enhancing overall quality of life. Tenofit 300 Tablet remains a trusted antiviral therapy, offering proven efficacy and safety in long-term management of viral infections.